These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36897999)

  • 1. TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma.
    Webersinke G; Burghofer J; Malli T; Rammer M; Jahn SW; Niendorf A; Tavassoli FA; Moinfar F
    Arch Pathol Lab Med; 2023 Dec; 147(12):1451-1457. PubMed ID: 36897999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of
    Zhong S; Zhou S; Li A; Lv H; Li M; Tang S; Xu X; Shui R; Yang W
    J Clin Pathol; 2022 Jul; 75(7):477-482. PubMed ID: 33952589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibromatosis-like metaplastic carcinoma: a case report and review of the literature.
    Victoor J; Bourgain C; Vander Borght S; Vanden Bempt I; De Rop C; Floris G
    Diagn Pathol; 2020 Mar; 15(1):20. PubMed ID: 32127014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
    Ng CKY; Piscuoglio S; Geyer FC; Burke KA; Pareja F; Eberle CA; Lim RS; Natrajan R; Riaz N; Mariani O; Norton L; Vincent-Salomon A; Wen YH; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2017 Jul; 23(14):3859-3870. PubMed ID: 28153863
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguous.
    Takano EA; Hunter SM; Campbell IG; Fox SB
    J Clin Pathol; 2015 May; 68(5):362-7. PubMed ID: 25713418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
    Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
    J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
    Bartels S; van Luttikhuizen JL; Christgen M; Mägel L; Luft A; Hänzelmann S; Lehmann U; Schlegelberger B; Leo F; Steinemann D; Kreipe H
    J Pathol; 2018 Jul; 245(3):373-383. PubMed ID: 29708279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
    Krings G; Chen YY
    Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
    Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
    PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
    Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
    Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromatosis-like metaplastic carcinoma of breast: a challenge for clinicopathologic diagnosis.
    Zhao Y; Gong X; Li N; Zhu B; Yu D; Jin X
    Int J Clin Exp Pathol; 2018; 11(7):3691-3696. PubMed ID: 31949751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors.
    Bellmunt J; Werner L; Leow JJ; Mullane SA; Fay AP; Riester M; Van Hummelen P; Taplin ME; Choueiri TK; Van Allen E; Rosenberg J
    PLoS One; 2015; 10(6):e0124711. PubMed ID: 26039708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence.
    Gobbi H; Simpson JF; Borowsky A; Jensen RA; Page DL
    Cancer; 1999 May; 85(10):2170-82. PubMed ID: 10326695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
    Pierobon M; Ramos C; Wong S; Hodge KA; Aldrich J; Byron S; Anthony SP; Robert NJ; Northfelt DW; Jahanzeb M; Vocila L; Wulfkuhle J; Gambara G; Gallagher RI; Dunetz B; Hoke N; Dong T; Craig DW; Cristofanilli M; Leyland-Jones B; Liotta LA; O'Shaughnessy JA; Carpten JD; Petricoin EF
    Clin Cancer Res; 2017 Aug; 23(16):4919-4928. PubMed ID: 28446508
    [No Abstract]   [Full Text] [Related]  

  • 16. PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
    Beelen K; Opdam M; Severson TM; Koornstra RH; Vincent AD; Wesseling J; Muris JJ; Berns EM; Vermorken JB; van Diest PJ; Linn SC
    Breast Cancer Res; 2014 Jan; 16(1):R13. PubMed ID: 24467828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.
    Stella S; Vitale SR; Massimino M; Motta G; Longhitano C; Lanzafame K; Martorana F; Fazzari C; Vecchio GM; Tirrò E; Inzerilli N; Carciotto R; Manzella L; Caruso M; Vigneri P
    Cancer Genomics Proteomics; 2022; 19(4):464-476. PubMed ID: 35732329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast.
    Sneige N; Yaziji H; Mandavilli SR; Perez ER; Ordonez NG; Gown AM; Ayala A
    Am J Surg Pathol; 2001 Aug; 25(8):1009-16. PubMed ID: 11474284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of metaplastic breast carcinoma via next-generation sequencing.
    Zhai J; Giannini G; Ewalt MD; Zhang EY; Invernizzi M; Niland J; Lai LL
    Hum Pathol; 2019 Apr; 86():85-92. PubMed ID: 30537493
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Amato O; Buisseret L; Gebhart G; Plouznikoff N; Larsimont D; Awada A; Piccart M; Aftimos P
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36863843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.